左旋多巴损害基底节在体能量代谢
这项双盲交叉安慰剂对照试验纳入20例帕金森病患者和22名健康对照,发现左旋多巴/苄丝肼治疗使基底节高能含磷代谢物大幅降低(患者-40%,对照-39%),中脑无变化,提示外源性左旋多巴对基底节能量代谢有显著干扰。
要点
- 左旋多巴/苄丝肼使基底节高能含磷代谢物降低约40%,中脑无变化。
- 帕金森病患者与健康对照的基线及治疗反应无差异。
- 外源性左旋多巴对基底节能量代谢的干扰可能局限于多巴胺作用部位。
核心结论
- 外源性左旋多巴/苄丝肼强烈干扰两组基底节高能含磷代谢物水平,中脑无影响,提示变化局限于多巴胺作用部位。
研究设计与样本
- 双盲、交叉、安慰剂对照试验;参与者分别接受200/50 mg左旋多巴/苄丝肼或安慰剂,第二次访视交换。
- 共纳入20例帕金森病患者(6例女性)和22名性别、年龄匹配的健康对照(10例女性)。
- 临床评估和多模态神经影像,包括基底节和中脑的31磷磁共振波谱。
主要发现
- 左旋多巴/苄丝肼治疗使基底节高能含磷代谢物大幅降低(帕金森病患者:-40%;健康对照:-39%),安慰剂无此效应。
- 中脑高能含磷代谢物无变化。
- 帕金森病患者与健康对照在OFF状态及治疗反应上高能含磷代谢物无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: One proposed mechanism of disease progression in Parkinson's disease includes the interplay of endogenous dopamine toxicity and mitochondrial dysfunction. However, the in-vivo effects of exogenous dopamine administration on cerebral bioenergetics are unknown. METHODS: We performed a double-blinded, cross-over, placebo-controlled trial. Participants received either 200/50 mg levodopa/benserazide or a placebo and vice versa on the second study visit. Clinical assessments and multimodal neuroimaging were performed, including 31phosphorus magnetic resonance spectroscopy of the basal ganglia and the midbrain. RESULTS: In total, 20 (6 female) patients with Parkinson's disease and 22 sex- and age-matched healthy controls (10 female) were enrolled. Treatment with levodopa/benserazide but not with placebo resulted in a substantial reduction of high-energy phosphorus-containing metabolites in the basal ganglia (patients with Parkinson's disease: -40%; healthy controls: -39%) but not in the midbrain. There were no differences in high-energy phosphorus-containing metabolites for patients with Parkinson's disease compared to healthy controls in the OFF state and treatment response. INTERPRETATION: Exogenously administered levodopa/benserazide strongly interferes with basal ganglia high-energy phosphorus-containing metabolite levels in both groups. The lack of effects on midbrain levels suggests that the observed changes are limited to the site of dopamine action. ANN NEUROL 2024;95:849-857.
引用
- Prasuhn J, Schiefen T, Güber T, et al. Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo. Ann Neurol. 2024. PMID: 38366778. doi:10.1002/ana.26884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。